300677 Intco Medical Technology
- 25.00
- -0.25-0.99%
Intco Medical Technology News
The US imposes 50% tariffs on some medical consumables in China, and consumables companies such as Inke Healthcare are under double pressure
The imposition of tariffs this time is undoubtedly another blow to British Healthcare.
British Healthcare (300677.SZ): Disposable gloves remained at full production and sales in the second quarter
Gelonghui May 10 丨 British Healthcare (300677.SZ) held a performance briefing on May 9, 2024 to discuss “What was the company's order situation in the second quarter, can production be fully completed, and what is the price of gloves?” The company replied that the company maintained full production and sales of disposable gloves in the second quarter, and that the price of gloves increased to a certain extent compared to the first quarter.
British Healthcare: Disposable gloves remained at full production and sales in the second quarter
Ingtech Healthcare's performance briefing was held on May 9. Inke Medical said that the company maintained full production and sales of disposable gloves in the second quarter, and the price of gloves increased to a certain extent compared to the first quarter. In addition, the price of nitrile latex has risen to a certain extent due to the increase in the price of its upstream raw material butadiene, but the company owns Anhui Kaize and Shandong Haode Holding Nitrile Latex Raw Material Factory for self-supply, so the impact of the increase in nitrile latex prices is relatively limited.
British Healthcare (300677): Industry inventory is bottoming out, and the company's glove business is expected to usher in a sharp rise in volume and price
Performance review The company released the 2023 annual report and the first quarter report of 2024. In 2023, the company achieved operating income of 6.919 billion yuan, an increase of 4.61% over the previous year; achieved net profit attributable to the owner of the parent company of 3.83
Deciphering the new investment trends of social security funds in the first quarter: the top ten tradable shareholders added to 220 individual stocks, and Inke Healthcare received the largest number of shareholders
① The first quarterly report of A-share listed companies was revealed, and a total of 667 shares of the top ten tradable shareholders were revealed; ② Among them, the Social Security Fund entered the list of the top ten tradable shareholders of 220 individual shares, with Inke Healthcare receiving the most additional holdings and the list of individual stocks with more than 2 additional holdings (attached table); ③ Zhejiang Electric Power received the most new shares in the first quarter, and Wanhua Chemical received the highest market value of new holdings.
Express News | British Healthcare: Net profit for the first quarter was 238 million yuan, up 255.63% year on year
British Healthcare (300677.SZ) announced its 2023 annual results, net profit of 383 million yuan, a decrease of 39.12%
British Healthcare (300677.SZ) released its 2023 annual report. During the reporting period, the company achieved operating income of 6...
Express News | Jindun Co., Ltd., Yingke Healthcare and others set up venture capital fund partnerships for 100 million yuan
Express News | British Healthcare: Give full play to the company's comprehensive competitive advantage and develop into a global industry leader
British Healthcare (300677.SZ): 0.69% of shares have been repurchased cumulatively
Gelonghui, March 1, 丨 British Healthcare (300677.SZ) announced that as of February 29, 2024, the company had repurchased 4,504,300 shares of the company's shares through a dedicated stock repurchase securities account, accounting for 0.6866% of the company's total share capital (based on calculation of 656,009,601 shares on February 29, 2024). The highest transaction price was 23.75 yuan/share, and the total transaction amount was RMB 100,015,581.00 (excluding transactions) costs).
British Healthcare (300677.SZ) has repurchased a total of 4,504,300 shares at a cost of 100 million yuan
British Healthcare (300677.SZ) announced that as of January 31, 2024, the company has repurchased 4 of the company's shares...
British Healthcare (300677.SZ): Intended to participate in Haining Qingling Venture Capital Fund Partnership
Gelonghui, January 25 | Yingke Healthcare (300677.SZ) announced that in order to further optimize the investment structure and enhance investment value, Inke Medical Technology Co., Ltd. plans to sign the “Haining Qingling Venture Capital Fund Partnership (Limited Partnership) Partnership Agreement” with Shanghai Rongxi Venture Capital Management Co., Ltd. (“Shanghai Rongxi”) to participate in investing in Haining Qingling Venture Capital Fund Partnership (limited partnership) (tentative name, subject to industrial and commercial approval, abbreviated as “partnership”, “fund” or “fund”). The total amount of capital pledged by the partnership is no more than 100 million yuan (the currency is human
Cross-border investment in the fields of pan-semiconductors, new energy and digitalization, British Healthcare (300677.SZ) plans to indirectly participate in the Feifan Science and Technology Innovation Fund
Zhitong Finance App News, British Healthcare (300677.SZ) announced that the company plans to sign the “Ganzhou Feifan Digital Influential Venture Capital Partnership (Limited Partnership) Partnership Agreement” with Shenzhen Feifan Digital Equity Investment Management Partnership (“Feifan Venture Capital”) to participate in investing in Ganzhou Feifan Digital Influential Venture Capital Partnership (Limited Partnership) with its own funds. The partnership's target total pledged capital is $147 million; of this, the company will pledge 30 million yuan as the limited partner (LP) of the partnership. According to the announcement, the partnership plans to target Pan-Semiconductors
Express News | British Healthcare: Intended to participate in investing in Ganzhou Feifan Digital Influential Venture Capital Partnership (limited partnership)
British Healthcare (300677.SZ): A total cost of 100 million yuan to buy back 4,504,300 shares
Gelonghui, January 2, 丨 British Healthcare (300677.SZ) announced that as of December 31, 2023, the company had repurchased a total of 4,504,300 shares of the company's shares through a dedicated stock repurchase securities account, accounting for 0.6866% of the company's total share capital (based on calculation of 656,004,151 shares on December 29, 2023). The maximum transaction price was 23.75 yuan/share, and the minimum transaction price was RMB 21.35 per share, and the total transaction amount was RMB 100 million (excluding transaction fees).
British Healthcare (300677.SZ): The annual GMV of online sales of Inke Medical gloves exceeded 400 million and ranked first in the domestic disposable gloves e-commerce market share
Gelonghui, December 29丨British Healthcare (300677.SZ) said on the investor interactive platform that the company is concerned about and is focusing on strengthening the “British Healthcare” brand building and establishing e-commerce clusters. In 2023, it ranked first in the sales rankings of medical gloves on mainstream e-commerce platforms such as Tmall and Pinduoduo. The total number of daily impressions on social e-commerce platforms such as Douyin, Kuaishou, and Xiaohongshu has exceeded 10 million. Fan stickiness has been effectively increased through methods such as natural flow ratio optimization, user interaction optimization, and user stay optimization. The GMV of online sales of Yingke Medical Gloves exceeded 400 million in the whole year, ranking first in the domestic e-commerce market share for disposable gloves.
British Medical (300677.SZ) has spent 69.58 million yuan to repurchase 3.194,500 shares
British Medical (300677.SZ) issued an announcement. As of November 30, 2023, the company has returned through shares...
The wholly-owned subsidiary of British Medical (300677.SZ) plans to spend a total of 30 million US dollars to participate in investment funds in professional investment institutions
Yingke Healthcare (300677.SZ) announced that Inke Healthcare International (Hong Kong) Limited, a wholly-owned subsidiary of the company (“...
British Medical (300677.SZ): As of the end of October, a total of 319.452 million shares have been repurchased
Gelonghui November 2 | British Medical (300677.SZ) announced that as of October 31, 2023, the company has repurchased a total of 319.452 million shares of the company's shares through a special stock repurchase account through centralized bidding transactions, accounting for 0.4848% of the company's total share capital (calculated based on the total share capital of 658,932,823 shares on October 31, 2023), and the maximum transaction price is 22.33 yuan/share. The minimum transaction price is 21.35 yuan/share, and the total transaction amount is RMB 69.57582 million (excluding transaction fees).
British Medical (300677.SZ) released the first three quarter results, net profit of 331 million yuan
British Medical (300677.SZ) released its report for the third quarter of 2023. The company achieved revenue of 5 in the first three quarters...
Analysis
Price Target
No Data
